Table 1.
Demographics of patients with OUD who died within 12 months of hospital discharge in Oregon, 2015–2018
| Non-drug related death (n=221) | Non-overdose drug-related death (n=230) | Overdose death (n=71) | p-value** | ||
|---|---|---|---|---|---|
| Sex | Male | 92 (41.6%) | 123 (53.5%) | 41 (57.7%) | 0.012 |
| Female | 129 (58.4%) | 107 (46.5%) | 30 (42.3%) | ||
| Age (years) | 58.1 (15.9) | 58.0 (12.4) | 43.2 (13.2) | 0.0012 | |
| Race | Black | 9 (4.1%) | 9 (3.9%) | * | 0.80 |
| White | 176 (79.6%) | 186 (80.9%) | 55 (77.5%) | ||
| Asian | 6 (2.7%) | 6 (2.6%) | 0 | ||
| Other | 30 (13.6%) | 29 (12.6%) | 13 (18.3%) | ||
| Ethnicity | Not Hispanic | 192 (86.9%) | 205 (89.1%) | 56 (78.9%) | 0.083 |
| Hispanic/Other | 29 (13.1%) | 25 (10.9%) | 15 (21.1%) | ||
| Length of stay (days) | 10.1 (14.0) | 9.7 (17.3) | 7.7 (13.9) | 0.39 | |
| Alcohol use disorder | Yes | * | 14 (6.1%) | 6 (8.5%) | 0.004 |
| Amphetamine use disorder | Yes | 10 (4.5%) | * | 13 (18.3%) | <0.001 |
| Sedative use disorder | Yes | * | 7 (3.0%) | * | 0.042 |
| Chronic Illness & Disability Payment System Score | 4.3 (2.0) | 4.1 (1.8) | 3.0 (1.5) | <0.0001 | |
*
Cells suppressed if n<=5
**
Assessed using Chi-squared tests, Fisher’s exact test, or Analysis of Variance